BioArts International to Clone Dogs and Cats
Pastor Dale Morgan
Start Licensing Grants BioArts International to Clone Dogs and Cats*
Wednesday May 21, 6:00 am ET
AUSTIN, Texas--(BUSINESS WIRE)--Start Licensing, Inc. (Start) today
announced that it has granted a sole, worldwide license for the cloning
of dogs, cats and endangered species to BioArts International, Ltd.
(BioArts) of Mill Valley, California. The license includes the grant of
an exclusive option to BioArts for exclusivity in dog and cat cloning.
“Our agreement strengthens BioArts’ position as the world’s leading
quality provider of companion animal cloning services,” said Jonathan
Thatcher, president of Start.
Start Licensing’s patents include foundational nuclear transfer cloning
technology developed at the Roslin Institute for the cloning of Dolly
the sheep. By obtaining a license to certain aspects of these patents,
BioArts will be able to employ a suite of sophisticated biotechnology
tools to produce healthy cloned animals.
“This license agreement allows us to leverage Start’s unique and vital
international role to cement our own position in the global market.
While other companies might claim capabilities in this area, BioArts is
the only entity in the world with both the know-how and the legal right
to practice commercial cat and dog cloning,” said Lou Hawthorne, Chief
Executive Officer of BioArts.
About Start Licensing
Start is a joint venture of Geron Corporation (Nasdaq:GERN - News) and
Exeter Life Sciences, Inc. Start manages and licenses a broad portfolio
of intellectual property rights related to animal reproductive
technologies, including foundational nuclear transfer cloning technology
developed at the Roslin Institute for the cloning of Dolly the sheep.
Start's licensees are on the cutting edge of research and product
development in food production, medical applications and many other fields.
About BioArts
BioArts International is a new biotech startup focused on unique,
untapped markets in the animal reproduction and human genomics industries.